NVST insider transaction filings

Envista Holdings Corp — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-27. Screen NVST transaction legs live →

Insider transaction summary — last 90 days

2026-06-24 to 2026-09-22, from the filings listed below: 7 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Reis Mischa — SVP, Strategy & Bus. Dev.11 leg · 8,000 sh · $220,000
Hammes Eric D. — Chief Financial Officer22
Keel Paul A — Chief Executive Officer, Director12
Acurio Veronica — President, Orthodontics11
Befidi Robert — President, Diagnostics11
Nilsson Stefan — President, Nobel Biocare11

Recent Form 4 filings — Envista Holdings Corp

FiledFormInsiderReported transactionsSource
2026-08-274Acurio Veronica — President, OrthodonticsTax withholding (F): 7,710 @ $27.47EDGAR
2026-08-274Befidi Robert — President, DiagnosticsTax withholding (F): 5,147 @ $27.47EDGAR
2026-08-274Nilsson Stefan — President, Nobel BiocareTax withholding (F): 804 @ $27.47EDGAR
2026-08-274Hammes Eric D. — Chief Financial OfficerTax withholding (F): 10,885 @ $27.47EDGAR
2026-08-244Reis Mischa — SVP, Strategy & Bus. Dev.Sale (S): 8,000 @ $27.50EDGAR
2026-08-204Keel Paul A — Chief Executive Officer, DirectorGrant/award (A): 179,730 @ $0 · Grant/award (A): 159,900 (derivative) @ $0EDGAR
2026-08-204Hammes Eric D. — Chief Financial OfficerGrant/award (A): 47,970 (derivative) @ $0EDGAR
2026-05-274Keel Paul A — Chief Executive Officer, DirectorTax withholding (F): 12,811 @ $23.43EDGAR
2026-05-214Pierce James Andrew — DirectorGrant/award (A): 9,330 @ $0EDGAR
2026-05-214Carruthers Wendy — DirectorGrant/award (A): 9,330 @ $0EDGAR
2026-05-214Jain Vivek — DirectorGrant/award (A): 9,330 @ $0EDGAR
2026-05-214Huennekens R Scott — DirectorGrant/award (A): 12,585 @ $0EDGAR
2026-05-214GALLAHUE KIERAN — DirectorGrant/award (A): 9,330 @ $0EDGAR
2026-05-214Raskas Daniel — DirectorGrant/award (A): 9,330 @ $0EDGAR
2026-05-214TSINGOS CHRISTINE A — DirectorGrant/award (A): 9,330 @ $0EDGAR
2026-02-274Acurio Veronica — President, OrthodonticsTax withholding (F): 1,412 @ $29.59 · Grant/award (A): 7,605 @ $0 · Grant/award (A): 13,845 (derivative) @ $0 · Grant/award (A): 18,020 (derivative) @ $0EDGAR
2026-02-274Nilsson Stefan — President, Nobel BiocareTax withholding (F): 182 @ $29.59 · Grant/award (A): 7,605 @ $0 · Grant/award (A): 13,845 (derivative) @ $0 · Grant/award (A): 18,020 (derivative) @ $0EDGAR
2026-02-274Befidi Robert — President, DiagnosticsTax withholding (F): 2,177 @ $29.59 · Grant/award (A): 7,605 @ $0 · Grant/award (A): 13,845 (derivative) @ $0 · Grant/award (A): 18,020 (derivative) @ $0EDGAR
2026-02-274Kaabi Faez C — Chief Accounting OfficerTax withholding (F): 4,964 @ $29.59 · Grant/award (A): 13,520 @ $0EDGAR
2026-02-274Reis Mischa — SVP, Strategy & Bus. Dev.Tax withholding (F): 2,976 @ $29.59 · Grant/award (A): 5,915 @ $0 · Grant/award (A): 10,770 (derivative) @ $0 · Grant/award (A): 14,020 (derivative) @ $0EDGAR
2026-02-274Nance Mark E — General CounselTax withholding (F): 3,368 @ $29.59 · Grant/award (A): 12,675 @ $0 · Grant/award (A): 23,070 (derivative) @ $0 · Grant/award (A): 30,040 (derivative) @ $0EDGAR
2026-02-274Keel Paul A — Chief Executive Officer, DirectorTax withholding (F): 11,840 @ $29.59 · Grant/award (A): 48,670 @ $0 · Grant/award (A): 132,885 (derivative) @ $0 · Grant/award (A): 115,320 (derivative) @ $0EDGAR
2026-02-274Hammes Eric D. — Chief Financial OfficerTax withholding (F): 2,045 @ $29.59 · Grant/award (A): 16,055 @ $0 · Grant/award (A): 29,225 (derivative) @ $0 · Grant/award (A): 38,040 (derivative) @ $0EDGAR
2026-02-114Reis Mischa — SVP, Strategy & Bus. Dev.Option exercise (M): 4,041 @ $19.04 · Sale (S): 4,041 @ $30 · Option exercise (M): 5,634 @ $15.97 · Sale (S): 5,634 @ $30 · Option exercise (M): 4,041 (derivative) @ $0 · Option exercise (M): 5,634 (derivative) @ $0EDGAR
2026-02-034Acurio Veronica — President, OrthodonticsGrant/award (A): 998 (derivative) @ $23.47EDGAR
2026-02-034Befidi Robert — President, DiagnosticsGrant/award (A): 998 (derivative) @ $23.47EDGAR
2026-02-034Kaabi Faez C — Chief Accounting OfficerGrant/award (A): 1,186 (derivative) @ $23.47EDGAR
2026-02-034Reis Mischa — SVP, Strategy & Bus. Dev.Grant/award (A): 2,919 (derivative) @ $21.71EDGAR
2026-02-034Nance Mark E — General CounselGrant/award (A): 2,006 (derivative) @ $23.47EDGAR
2026-02-034Keel Paul A — Chief Executive Officer, DirectorGrant/award (A): 4,091 (derivative) @ $23.47EDGAR
2026-02-034Hammes Eric D. — Chief Financial OfficerGrant/award (A): 1,119 (derivative) @ $23.47EDGAR
2025-11-044Keel Paul A — Chief Executive Officer, DirectorTax withholding (F): 54,097 @ $20.35EDGAR
2025-08-274Acurio Veronica — President, OrthodonticsTax withholding (F): 5,422 @ $21.12EDGAR
2025-08-274Nilsson Stefan — President, Nobel BiocareTax withholding (F): 804 @ $21.12EDGAR
2025-08-274Befidi Robert — President, DiagnosticsTax withholding (F): 3,454 @ $21.12EDGAR
2025-08-274Reis Mischa — SVP, Strategy & Bus. Dev.Sale (S): 15,000 @ $21.60EDGAR
2025-08-274Hammes Eric D. — Chief Financial OfficerTax withholding (F): 7,654 @ $21.12EDGAR
2025-07-164Pierce James Andrew — DirectorGrant/award (A): 9,155 @ $0EDGAR
2025-06-124Hulit Barbara B. — DirectorGrant/award (A): 10,450 @ $0EDGAR
2025-06-124Carruthers Wendy — DirectorGrant/award (A): 10,450 @ $0EDGAR
2025-06-124Jain Vivek — DirectorGrant/award (A): 10,450 @ $0EDGAR
2025-06-124Huennekens R Scott — DirectorGrant/award (A): 14,370 @ $0EDGAR
2025-06-124GALLAHUE KIERAN — DirectorGrant/award (A): 10,450 @ $0EDGAR
2025-06-124Raskas Daniel — DirectorGrant/award (A): 10,450 @ $0EDGAR
2025-06-124TSINGOS CHRISTINE A — DirectorGrant/award (A): 10,450 @ $0EDGAR
2025-05-274Keel Paul A — Chief Executive Officer, DirectorTax withholding (F): 12,787 @ $16.72EDGAR
2025-02-274Befidi Robert — President, DiagnosticsTax withholding (F): 1,123 @ $20.66 · Grant/award (A): 10,290 @ $0 · Grant/award (A): 18,960 (derivative) @ $0 · Grant/award (A): 24,010 (derivative) @ $0EDGAR
2025-02-274Nance Mark E — General CounselTax withholding (F): 3,691 @ $20.66 · Grant/award (A): 18,155 @ $0 · Grant/award (A): 33,455 (derivative) @ $0 · Grant/award (A): 42,370 (derivative) @ $0EDGAR
2025-02-274Keel Paul A — Chief Executive Officer, DirectorGrant/award (A): 65,830 @ $0 · Grant/award (A): 181,985 (derivative) @ $0 · Grant/award (A): 153,660 (derivative) @ $0EDGAR
2025-02-274Hammes Eric D. — Chief Financial OfficerGrant/award (A): 15,735 @ $0 · Grant/award (A): 28,995 (derivative) @ $0 · Grant/award (A): 36,720 (derivative) @ $0EDGAR

Recent 8-K events — Envista Holdings Corp

FiledFormItems reportedSource
2026-09-178-K7.01 — Regulation FD DisclosureEDGAR
2026-08-198-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-058-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-038-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-218-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-068-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-058-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-298-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-298-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-09-178-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=NVST returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →